ID   ANKK1_HUMAN             Reviewed;         765 AA.
AC   Q8NFD2;
DT   24-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   12-OCT-2022, entry version 152.
DE   RecName: Full=Ankyrin repeat and protein kinase domain-containing protein 1;
DE            EC=2.7.11.1;
DE   AltName: Full=Protein kinase PKK2;
DE   AltName: Full=Sugen kinase 288;
DE            Short=SgK288;
DE   AltName: Full=X-kinase;
GN   Name=ANKK1; Synonyms=PKK2, SGK288;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=15146457; DOI=10.1002/humu.20039;
RA   Neville M.J., Johnstone E.C., Walton R.T.;
RT   "Identification and characterization of ANKK1: a novel kinase gene closely
RT   linked to DRD2 on chromosome band 11q23.1.";
RL   Hum. Mutat. 23:540-545(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Inohara N.;
RL   Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], TISSUE SPECIFICITY, AND VARIANT LYS-713.
RX   PubMed=14741327; DOI=10.1016/s0920-9964(03)00220-2;
RA   Dubertret C., Gouya L., Hanoun N., Deybach J.-C., Ades J., Hamon M.,
RA   Gorwood P.;
RT   "The 3' region of the DRD2 gene is involved in genetic susceptibility to
RT   schizophrenia.";
RL   Schizophr. Res. 67:75-85(2004).
RN   [4]
RP   IDENTIFICATION.
RX   PubMed=12471243; DOI=10.1126/science.1075762;
RA   Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S.;
RT   "The protein kinase complement of the human genome.";
RL   Science 298:1912-1934(2002).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] TYR-4; HIS-122; THR-239; LEU-276; ARG-318;
RP   THR-347; PHE-366; GLN-367; LYS-376; LYS-426; ARG-442; ARG-451; ARG-490;
RP   ILE-595; LEU-596; SER-653; GLY-670; LYS-713; LEU-717; LEU-736 AND LYS-764.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- INTERACTION:
CC       Q8NFD2; Q99622: C12orf57; NbExp=3; IntAct=EBI-13280688, EBI-2808472;
CC       Q8NFD2; Q53TS8: C2CD6; NbExp=3; IntAct=EBI-13280688, EBI-739879;
CC       Q8NFD2; P15882: CHN1; NbExp=3; IntAct=EBI-13280688, EBI-718947;
CC       Q8NFD2; P52757: CHN2; NbExp=3; IntAct=EBI-13280688, EBI-714925;
CC       Q8NFD2; Q9NWT6: HIF1AN; NbExp=4; IntAct=EBI-13280688, EBI-745632;
CC       Q8NFD2; O95619: YEATS4; NbExp=4; IntAct=EBI-13280688, EBI-399269;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain and weakly expressed in
CC       placenta and spinal cord. {ECO:0000269|PubMed:14741327,
CC       ECO:0000269|PubMed:15146457}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ541797; CAD62569.2; -; mRNA.
DR   EMBL; AF487542; AAQ09005.1; -; mRNA.
DR   EMBL; AF525298; AAM91924.1; -; Genomic_DNA.
DR   CCDS; CCDS44734.1; -.
DR   RefSeq; NP_848605.1; NM_178510.1.
DR   AlphaFoldDB; Q8NFD2; -.
DR   SMR; Q8NFD2; -.
DR   BioGRID; 129088; 21.
DR   IntAct; Q8NFD2; 18.
DR   STRING; 9606.ENSP00000306678; -.
DR   BindingDB; Q8NFD2; -.
DR   ChEMBL; CHEMBL5547; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q8NFD2; -.
DR   iPTMnet; Q8NFD2; -.
DR   PhosphoSitePlus; Q8NFD2; -.
DR   BioMuta; ANKK1; -.
DR   DMDM; 74762569; -.
DR   jPOST; Q8NFD2; -.
DR   MassIVE; Q8NFD2; -.
DR   MaxQB; Q8NFD2; -.
DR   PaxDb; Q8NFD2; -.
DR   PeptideAtlas; Q8NFD2; -.
DR   PRIDE; Q8NFD2; -.
DR   Antibodypedia; 2098; 113 antibodies from 28 providers.
DR   DNASU; 255239; -.
DR   Ensembl; ENST00000303941.4; ENSP00000306678.3; ENSG00000170209.5.
DR   GeneID; 255239; -.
DR   KEGG; hsa:255239; -.
DR   MANE-Select; ENST00000303941.4; ENSP00000306678.3; NM_178510.2; NP_848605.1.
DR   UCSC; uc001pny.3; human.
DR   CTD; 255239; -.
DR   DisGeNET; 255239; -.
DR   GeneCards; ANKK1; -.
DR   HGNC; HGNC:21027; ANKK1.
DR   HPA; ENSG00000170209; Tissue enhanced (skin).
DR   MIM; 608774; gene.
DR   neXtProt; NX_Q8NFD2; -.
DR   OpenTargets; ENSG00000170209; -.
DR   PharmGKB; PA134872551; -.
DR   VEuPathDB; HostDB:ENSG00000170209; -.
DR   eggNOG; KOG0192; Eukaryota.
DR   GeneTree; ENSGT00940000162060; -.
DR   HOGENOM; CLU_015188_1_0_1; -.
DR   InParanoid; Q8NFD2; -.
DR   OMA; SIYGVCR; -.
DR   OrthoDB; 1112022at2759; -.
DR   PhylomeDB; Q8NFD2; -.
DR   TreeFam; TF106506; -.
DR   PathwayCommons; Q8NFD2; -.
DR   SignaLink; Q8NFD2; -.
DR   BioGRID-ORCS; 255239; 8 hits in 1101 CRISPR screens.
DR   GeneWiki; ANKK1; -.
DR   GenomeRNAi; 255239; -.
DR   Pharos; Q8NFD2; Tbio.
DR   PRO; PR:Q8NFD2; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q8NFD2; protein.
DR   Bgee; ENSG00000170209; Expressed in right uterine tube and 86 other tissues.
DR   ExpressionAtlas; Q8NFD2; baseline and differential.
DR   GO; GO:0042995; C:cell projection; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   GO; GO:0010564; P:regulation of cell cycle process; IDA:MGI.
DR   Gene3D; 1.25.40.20; -; 5.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 3.
DR   Pfam; PF13637; Ank_4; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 11.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 11.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; ATP-binding; Kinase; Nucleotide-binding; Reference proteome;
KW   Repeat; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..765
FT                   /note="Ankyrin repeat and protein kinase domain-containing
FT                   protein 1"
FT                   /id="PRO_0000085620"
FT   DOMAIN          22..289
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REPEAT          361..390
FT                   /note="ANK 1"
FT   REPEAT          394..423
FT                   /note="ANK 2"
FT   REPEAT          427..456
FT                   /note="ANK 3"
FT   REPEAT          460..489
FT                   /note="ANK 4"
FT   REPEAT          493..522
FT                   /note="ANK 5"
FT   REPEAT          526..555
FT                   /note="ANK 6"
FT   REPEAT          559..588
FT                   /note="ANK 7"
FT   REPEAT          592..621
FT                   /note="ANK 8"
FT   REPEAT          625..654
FT                   /note="ANK 9"
FT   REPEAT          658..687
FT                   /note="ANK 10"
FT   REPEAT          691..720
FT                   /note="ANK 11"
FT   REPEAT          724..753
FT                   /note="ANK 12"
FT   ACT_SITE        145
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         28..36
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         51
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   VARIANT         4
FT                   /note="D -> Y (in dbSNP:rs35657708)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040359"
FT   VARIANT         122
FT                   /note="R -> H (in dbSNP:rs35877321)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040360"
FT   VARIANT         239
FT                   /note="A -> T (in dbSNP:rs7118900)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_036784"
FT   VARIANT         276
FT                   /note="P -> L (in dbSNP:rs35488601)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040361"
FT   VARIANT         318
FT                   /note="G -> R (in dbSNP:rs11604671)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_036785"
FT   VARIANT         347
FT                   /note="K -> T (in a breast infiltrating ductal carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040362"
FT   VARIANT         366
FT                   /note="L -> F (in dbSNP:rs56339158)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040363"
FT   VARIANT         367
FT                   /note="H -> Q (in dbSNP:rs34298987)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040364"
FT   VARIANT         376
FT                   /note="E -> K (in dbSNP:rs56299709)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040365"
FT   VARIANT         426
FT                   /note="E -> K (in dbSNP:rs55699907)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040366"
FT   VARIANT         442
FT                   /note="G -> R (in dbSNP:rs4938016)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_036786"
FT   VARIANT         451
FT                   /note="G -> R (in dbSNP:rs34983219)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040367"
FT   VARIANT         490
FT                   /note="H -> R (in dbSNP:rs2734849)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_036787"
FT   VARIANT         595
FT                   /note="T -> I (in dbSNP:rs55787008)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040368"
FT   VARIANT         596
FT                   /note="P -> L (in dbSNP:rs7104979)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040369"
FT   VARIANT         653
FT                   /note="N -> S (in dbSNP:rs55849504)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040370"
FT   VARIANT         670
FT                   /note="S -> G (in dbSNP:rs56006094)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040371"
FT   VARIANT         713
FT                   /note="E -> K (in dbSNP:rs1800497)"
FT                   /evidence="ECO:0000269|PubMed:14741327,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_025010"
FT   VARIANT         717
FT                   /note="Q -> L (in a lung large cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040372"
FT   VARIANT         736
FT                   /note="R -> L (in a lung squamous cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040373"
FT   VARIANT         764
FT                   /note="E -> K (in a lung neuroendocrine carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040374"
SQ   SEQUENCE   765 AA;  84632 MW;  549F6161B2976BF5 CRC64;
     MAADPTELRL GSLPVFTRDD FEGDWRLVAS GGFSQVFQAR HRRWRTEYAI KCAPCLPPDA
     ASSDVNYLIE EAAKMKKIKF QHIVSIYGVC KQPLGIVMEF MANGSLEKVL STHSLCWKLR
     FRIIHETSLA MNFLHSIKPP LLHLDLKPGN ILLDSNMHVK ISDFGLSKWM EQSTRMQYIE
     RSALRGMLSY IPPEMFLESN KAPGPKYDVY SFAIVIWELL TQKKPYSGFN MMMIIIRVAA
     GMRPSLQPVS DQWPSEAQQM VDLMKRCWDQ DPKKRPCFLD ITIETDILLS LLQSRVAVPE
     SKALARKVSC KLSLRQPGEV NEDISQELMD SDSGNYLKRA LQLSDRKNLV PRDEELCIYE
     NKVTPLHFLV AQGSVEQVRL LLAHEVDVDC QTASGYTPLL IAAQDQQPDL CALLLAHGAD
     ANRVDEDGWA PLHFAAQNGD DGTARLLLDH GACVDAQERE GWTPLHLAAQ NNFENVARLL
     VSRQADPNLH EAEGKTPLHV AAYFGHVSLV KLLTSQGAEL DAQQRNLRTP LHLAVERGKV
     RAIQHLLKSG AVPDALDQSG YGPLHTAAAR GKYLICKMLL RYGASLELPT HQGWTPLHLA
     AYKGHLEIIH LLAESHANMG ALGAVNWTPL HLAARHGEEA VVSALLQCGA DPNAAEQSGW
     TPLHLAVQRS TFLSVINLLE HHANVHARNK VGWTPAHLAA LKGNTAILKV LVEAGAQLDV
     QDGVSCTPLQ LALRSRKQGI MSFLEGKEPS VATLGGSKPG AEMEI
//
